Affiliation:
1. Mashhad University of medical sciences
2. Isfahan University of Medical Sciences
3. Loma Linda University
4. Binghamton University
Abstract
Abstract
Background:
This study aimed to establish a 10 year dyslipidemia incidence model, investigating novel anthropometric indices using exploratory regression and data mining.
Methods:
A total of 1776 individuals without dyslipidemia were enrolled from phase 1 of the Mashhad Stroke and Heart Atherosclerotic Disorder (MASHAD) study. People who were diagnosed with dyslipidemia in phase 2 (n = 1097) were compared with healthy people in this phase. The association of dyslipidemia with novel anthropometric indices including C-Index (conicity index), BRI (body roundness index), VAI (Visceral Adiposity Index), LAP (Lipid Accumulation Product), AVI (Abdominal volume index), WWI (weight-adjusted-waist index), BMI (body mass index), BAI (Body Adiposity Index) and BSA (body surface area) have been evaluated in this study. Logistic regression (LR) and decision tree (DT) analysis were utilized to evaluate the association. The accuracy, sensitivity, and specificity of DT were assessed through the performance of a receiver operating characteristic (ROC) curve using R software.
Results:
A total of 1776 subjects including 1097 and 679 individuals with and without dyslipidemia encountered the study. There were 586 (53.4%) females and 511(46.6%) males with dyslipidemia. According to the results, VAI has been identified as the most significant risk factor for dyslipidemia (OR: 2.81, (95% CI: 2.07, 3.81)) in all models. Moreover, the DT showed that VAI followed by BMI and LAP as the most critical variables in the prediction of dyslipidemia incidence.
Conclusions:
Based on our findings, the VAI was the principal anthropometric factor for predicting dyslipidemia incidence.
Publisher
Research Square Platform LLC
Reference40 articles.
1. Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017;Amini M;BMC Public Health,2021
2. Detection, NCEPEPo. Adults ToHBCi. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): The Program; 2002.
3. Relationship between hyperlipidemia, cardiovascular disease and stroke: a systematic review;Alloubani A;Curr Cardiol Rev,2021
4. Body mass index and the prevalence of hypertension and dyslipidemia;Brown CD;Obes Res,2000
5. Prevalence of dyslipidemia in urban and rural India: the ICMR–INDIAB study;Joshi SR;PLoS ONE,2014